evels of hemostasis factors after pregnancy

Recruiting

• Conditions: increased inclination to clotting; thrombophilia; 10064477

• Registration Number: NL-OMON35473
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

uncomplicated pregnancy, age > 18 years

Exclusion Criteria

complicated pregnancy (preeclampsia, HELLP-syndrome), history of repeated miscariages, growth retardation, hemostasis abnormalities

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Concentration of hemostasis factors (Activated Protein C, protein C, protein S,<br /><br>APTT, trombotest, antitrombin, factor V Leiden, protrombine, lupus<br /><br>anticoagulans-test, anti-cardiolipine antibodies, von Willebrand factor)</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>n.a. </p><br>